Eating Experiences During Cancer Treatment in Adolescents and Young Adults: A Systematic Literature Review and Meta-Synthesis.

J Adolesc Young Adult OncolJan 21, 2026 (epub)

Marie Ernst Christensen, Rakel B Jónsdóttir, Sigrún Sunna Skúladóttir et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic literature review and qualitative meta-synthesis examined eating experiences and mealtime-related well-being among adolescents and young adults aged 15–39 receiving cancer treatment. Eighteen qualitative or mixed-method studies were included, representing 302 AYAs, 73 relatives, and 88 health care professionals. The synthesis identified a central theme of eating as both an embodied struggle and an act of agency, shaped by physical and sensory disruption, emotional and relational changes, and gaps in support. The authors developed 13 evidence-informed recommendations for clinical application.

Key findings

  • The review included 18 studies representing 302 AYAs, 73 relatives, and 88 health care professionals.
  • The core theme was eating as an embodied struggle and act of agency, with physical, emotional, relational, and support-related dimensions.
  • Thirteen evidence-informed recommendations emphasized early nutritional screening, dietetic support, flexible meals, respectful family involvement, and psychosocially attuned care.

Why it matters

Eating difficulties during cancer treatment can involve more than nutrition, encompassing sensory and physical disruption, emotional distress, relationships, and access to support. Recognizing these interconnected experiences may help care teams respond in ways that respect young people’s agency and individual circumstances, while addressing eating-related quality of life.

What to keep in mind

The synthesis draws on qualitative and mixed-method studies, so it identifies experiences and informs recommendations but does not establish the effectiveness of specific interventions.

Source

Published in J Adolesc Young Adult Oncol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.